Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zentalis Pharmaceuticals Inc (NQ: ZNTL )

17.20 +0.57 (+3.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 560,492
Open 16.67
Bid (Size) 16.15 (1)
Ask (Size) 18.26 (1)
Prev. Close 16.63
Today's Range 16.61 - 17.53
52wk Range 15.55 - 52.85
Shares Outstanding 45,052,904
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks That Hit 52-Week Lows On Friday
  On Friday, 497 companies set new 52-week lows. 
Via Benzinga
Newman Ferrara LLP Announces Corporate Governance Investigations of Zentalis Pharmaceuticals, Inc. (ZNTL)
From Newman Ferrara LLP
Via Business Wire

Performance

YTD
-16.71%
-16.71%
1 Month
-10.23%
-10.23%
3 Month
-16.71%
-16.71%
6 Month
-22.56%
-22.56%
1 Year
-63.07%
-63.07%

More News

Read More
4 Analysts Have This to Say About Zentalis Pharmaceuticals
Via Benzinga
Oppenheimer Maintains Outperform Rating for Zentalis Pharmaceuticals: Here's What You Need To Know
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Via Benzinga
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Via Benzinga
This Analyst Says Zentalis' Increased Focus On WEE1 Program Is 'Prudent', Slashes Price Target By 37%
Via Benzinga
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Citigroup Slashes Price Target On This Stock By 83%; Also Check Out Some Other Big PT Changes
Via Benzinga
Zentalis Pharmaceuticals: Q2 Earnings Insights
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
Via Benzinga
Advanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression
Via FinancialNewsMedia
Topics Death
Exposures Death
Recap: Zentalis Pharmaceuticals Q1 Earnings
Via Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
73 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
Via Benzinga
61 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Zentalis Pharma Posts Initial Clinical Data On Its Wee1 Inhibitor In Ovarian Cancer
Via Benzinga
28 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.